Short answer
LB PHARMACEUTICALS INC (LBRX) filed an 8-K current report with the SEC on June 9, 2026 reporting Item 5.07 (Submission of Matters to a Vote of Security Holders). Three Class I directors elected for terms ending at the 2029 annual meeting.
LB PHARMACEUTICALS INC 8-K event analysis
AI summary of each reported item and its exhibits
Item 5.07 · Submission of Matters to a Vote of Security Holders
- Three Class I directors elected for terms ending at the 2029 annual meeting
- Robert A. Lenz received 20,059,577 votes, with 3,216,636 broker non-votes
- Rebecca Luse and Ran Nussbaum elected despite 1,536,901 and 1,319,070 withheld votes
- BDO USA, P.C. appointment ratified for fiscal year ending December 31, 2026
- Auditor ratification received 23,275,974 votes for versus 5,490 against
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other LB PHARMACEUTICALS INC 8-K filings
Get the next LBRX 8-K as it lands
Follow LBRX for push alerts, or ask the research agent what this filing means.